Policy and Practice Strategies to Address the Clinical Practice Gaps Affecting the Implementation of Personalized Medicine in Cancer Care
Co-Organized with Personalized Medicine Coalition (PMC)


MODERATOR:
Daryl Pritchard, PhD, Senior Vice President, Science Policy, Personalized Medicine Coalition

PANELISTS:
Robert H. Dumanois, Director, Reimbursement Strategy, Thermo Fisher Scientific

Anthony N. Sireci, MD, MSc, Senior Vice President, Clinical Biomarkers & Diagnostics Division, Loxo Oncology, Inc.

Apostolia-Maria Tsimberidou, MD, PhD, FASCO, FAASS, Professor of Medicine, Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center